CancerFax
Baruch Brenner
verifiedCancerFax Verified
schoolMD, Medical Oncology

Dr. Baruch Brenner

MD, Medical Oncology

Professor of Oncology & Director, Davidoff Cancer Center

corporate_fareDavidoff Cancer Center, Rabin Medical Center, Israel

check_circleGI Oncology
check_circleColorectal Cancer
check_circleImmunotherapy
check_circleClinical Trials
INSTITUTION
corporate_fareDavidoff Cancer Center, Rabin Medical Center
DEPARTMENT
scienceMedical & GI Oncology
SPECIALTY
medical_servicesGastrointestinal & Colorectal Cancer
LOCATION
location_onPetah Tikva, Israel
INTERNATIONAL PATIENTS
publicInternational Patients Welcome
person

Baruch Brenner

MD, Medical Oncology

Prof. Baruch Brenner is a medical oncologist specialising in gastrointestinal cancers at the Davidoff Cancer Center, Rabin Medical Center, Israel. He serves as Director of the Davidoff Center and holds the position of Associate Professor of Oncology at the Sackler School of Medicine, Tel Aviv University.

Prof. Brenner's clinical focus encompasses colorectal cancer, colon and rectal cancer, gastric cancer, and biliary tract malignancies, with systemic therapy, immunotherapy, and translational research as core areas of work. The Gastrointestinal Oncology Unit at Davidoff Center, where Prof. Brenner is a central figure, conducts Phase I to Phase IV clinical trials in partnership with international research organisations and biotechnology companies. Tel Aviv University's research portal lists more than 165 research outputs attributed to him, spanning peer-reviewed publications in colorectal cancer prediction, gastric and oesophagogastric junction cancer immunotherapy, and rectal cancer treatment strategies. For patients with complex gastrointestinal malignancies, his profile is particularly relevant for multidisciplinary treatment planning, systemic therapy evaluation, and clinical trial suitability assessment.

calendar_month
M
Visiting Days
public
International Patients

CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Brenner, subject to hospital availability and case acceptance.

stars

Why Consider Prof. Baruch Brenner?

Prof. Brenner combines clinical leadership in gastrointestinal oncology, a substantive academic research profile, and active involvement in Phase I–IV clinical trials at one of Israel's foremost cancer centres.

local_hospital
Director, Davidoff Cancer Center
Prof. Brenner leads the Davidoff Cancer Center at Rabin Medical Center, one of Israel's major oncology treatment and research institutions offering multidisciplinary, personalised cancer care.
science
Phase I–IV GI Cancer Clinical Trials
The Gastrointestinal Oncology Unit at Davidoff Center conducts clinical trials across all phases, with Prof. Brenner involved in research spanning colorectal, gastric, rectal, and biliary tract cancers.
biotech
Immunotherapy in Gastrointestinal Cancers
Prof. Brenner's research includes immunotherapy approaches for gastric, oesophagogastric junction, and rectal cancers, with findings presented at international forums including ESMO Gastrointestinal Tumours.
verified
Extensive Academic Publication Record
With more than 165 research outputs listed on Tel Aviv University's research portal, Prof. Brenner has a substantive academic contribution to the field of gastrointestinal oncology.
verified_user

Areas of Specialisation

Focused gastrointestinal oncology expertise spanning colorectal, gastric, biliary, and rectal malignancies

Prof. Brenner's clinical and research work covers the full spectrum of gastrointestinal malignancies, with particular depth in colorectal cancer, gastric cancer, biliary tract cancer, and rectal cancer. His involvement in clinical trials and translational research at Davidoff Center adds a research dimension to his clinical practice.

Treatment Specialties

Colorectal & Rectal Cancer

Systemic treatment planning for colon, rectal, and colorectal cancer including advanced and metastatic disease.

starsSystemic Therapy for Colorectal Cancer
  • arrow_rightChemotherapy protocols for localised and metastatic colorectal cancer
  • arrow_rightLater-line therapy options including mitomycin C and capecitabine combinations
  • arrow_rightBiomarker-guided treatment selection where applicable
starsRectal Cancer Treatment
  • arrow_rightPreoperative systemic therapy approaches in rectal cancer
  • arrow_rightResearch-based combination of immunotherapy and chemoradiotherapy for selected patients
  • arrow_rightMultidisciplinary rectal cancer case review

Gastric & Biliary Tract Cancer

Treatment planning and research-based approaches for gastric, oesophagogastric junction, and biliary tract malignancies.

starsGastric & Oesophagogastric Junction Cancer
  • arrow_rightAdjuvant immunotherapy after preoperative chemotherapy in high-risk gastric cancer
  • arrow_rightSystemic therapy planning for gastric and oesophagogastric junction malignancies
  • arrow_rightParticipation in international gastric cancer research studies (EORTC VESTIGE)
starsBiliary Tract Cancer
  • arrow_rightSystemic treatment evaluation for biliary tract malignancies
  • arrow_rightMultidisciplinary case review for complex biliary cancer presentations

Clinical Trials & Translational Research

Active involvement in Phase I–IV clinical research in gastrointestinal oncology at Davidoff Cancer Center, Rabin Medical Center.

starsGI Oncology Clinical Trial Programme
  • arrow_rightPhase I to Phase IV gastrointestinal oncology trials at Davidoff Cancer Center
  • arrow_rightCollaboration with international research bodies and biotechnology organisations
  • arrow_rightClinical trial suitability evaluation for eligible patients
Clinical Focus Areas
check_circleColorectal & Colon Cancer
check_circleRectal Cancer
check_circleGastric Cancer
check_circleBiliary Tract Cancer
check_circleImmunotherapy in GI Cancers
check_circleGastrointestinal Clinical Trials
medical_services

Procedures & Clinical Approaches

Medical oncology services for gastrointestinal malignancies

Prof. Brenner's clinical practice is in medical oncology for gastrointestinal cancers, covering systemic therapy administration, immunotherapy-based approaches, clinical trial enrolment evaluation, and multidisciplinary treatment planning.

Systemic Cancer Treatment

Medical Oncology

Systemic treatment planning for gastrointestinal cancers including chemotherapy, targeted therapy, and immunotherapy for eligible patients.

Treatment Approaches
arrow_rightChemotherapy protocols for colorectal, gastric, and biliary tract cancers
arrow_rightImmunotherapy for eligible gastrointestinal cancer patients
arrow_rightTargeted and biological cancer therapy guided by biomarker profile
arrow_rightLater-line therapy evaluation for metastatic colorectal cancer

Clinical Trial Evaluation

Complex Disease

Assessment of patient eligibility for Phase I–IV gastrointestinal oncology clinical trials conducted at the Davidoff Cancer Center.

Trial Participation Assessment
arrow_rightEligibility review for ongoing GI oncology clinical trials
arrow_rightResearch-based treatment options for selected patients
arrow_rightCollaboration with international trial sponsors and scientific institutions

Multidisciplinary Cancer Planning

Multidisciplinary

Multidisciplinary case reviews for complex gastrointestinal malignancies, integrating medical, surgical, and radiological inputs.

Team-Based Oncology Care
arrow_rightMultidisciplinary review of complex gastrointestinal cancer cases
arrow_rightTreatment sequencing for advanced and metastatic GI cancers
arrow_rightCoordination with surgical and radiation oncology teams where applicable

Second Opinion Consultations

Second Opinion

Specialist second-opinion review for gastrointestinal cancer cases including diagnosis verification, staging assessment, and alternative treatment pathway evaluation.

Second Opinion Process
arrow_rightIndependent review of pathology reports, imaging, and prior treatment history
arrow_rightAssessment of diagnosis and staging accuracy for GI malignancies
arrow_rightAlternative treatment pathway recommendations where appropriate
menu_book

Research & Publications

Peer-reviewed contributions and clinical trial involvement in gastrointestinal oncology

Prof. Brenner has a substantial academic publication record in gastrointestinal oncology. Tel Aviv University's research portal lists more than 165 research outputs attributed to him, spanning colorectal cancer, gastric malignancies, immunotherapy, and translational oncology research.

Selected Peer-Reviewed Publications
arrow_rightAdjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer (EORTC 1707 VESTIGE study) — Annals of Oncology, 2025
arrow_rightDevelopment and Validation of a Colorectal Cancer Prediction Model: A Nationwide Cohort Study using Electronic Health Records — PubMed / PMC
arrow_rightMitomycin C and capecitabine as later-line therapy for metastatic colorectal cancer — World Journal of Gastrointestinal Oncology, 2023
Clinical Research & Trial Contributions
arrow_rightLead investigator in Davidoff Center study on combined immunotherapy and chemoradiotherapy for rectal cancer, with preliminary findings presented at ESMO Gastrointestinal Tumours meeting (2024)
arrow_rightPhase I–IV gastrointestinal oncology clinical trial programme at Davidoff Cancer Center, covering colorectal, gastric, and biliary tract cancers
arrow_rightTranslational research collaborations with international scientific institutions and biotechnology organisations in gastrointestinal malignancies
Research Profile

More than 165 research outputs are attributed to Prof. Brenner on Tel Aviv University's research portal. A full publication list is available through the university's academic directory.

school

Education & Training

Prof. Brenner holds a medical degree and serves as Associate Professor of Oncology at the Sackler School of Medicine, Tel Aviv University. Full details of his undergraduate and postgraduate training institutions are not confirmed from publicly available official sources.

scheduleUndergraduate institution, postgraduate training programme details, and training years are not publicly confirmed from official sources. Please verify with Rabin Medical Center or Tel Aviv University faculty records before publishing.
work_history

Clinical Experience

Prof. Brenner is Director of the Davidoff Cancer Center at Rabin Medical Center, one of Israel's major oncology treatment and research centres, and concurrently holds the position of Associate Professor of Oncology at Tel Aviv University.

Director, Davidoff Cancer Center
Rabin Medical Center
Gastrointestinal Oncology Unit, Davidoff Cancer Center
check_circleGastrointestinal Cancer Oncology
check_circleColorectal & Rectal Cancer Treatment
check_circleImmunotherapy in GI Malignancies
check_circlePhase I–IV Clinical Trial Management
check_circleAcademic Medical Oncology, Tel Aviv University
check_circleMultidisciplinary GI Cancer Case Review
language

Languages & International

Prof. Brenner consults in the following languages. Please verify additional languages directly with the Davidoff Cancer Center or Rabin Medical Center.

🇬🇧English
🇮🇱Hebrew
Interpreter Support Available

CancerFax can coordinate professional medical interpreter support for international patients seeking a consultation with Prof. Brenner.

CancerFax can coordinate professional medical interpreter support for international patients consulting Prof. Brenner.

support_agentHow CancerFax Helps

How CancerFax Helps You Access Dr. Baruch Brenner

CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Baruch Brenner's team — with full coordination from initial inquiry to consultation.

description

Medical Report Review

Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Baruch Brenner's team.

medical_services

Treatment Eligibility Screening

CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Baruch Brenner before you travel, so you arrive with a clear pathway.

send

Case Submission

We coordinate direct case submission to Dr. Baruch Brenner's department, including all documentation required for clinical review and appointment scheduling.

calendar_month

Appointment & Consultation Coordination

CancerFax manages appointment scheduling with Dr. Baruch Brenner's team, confirming availability and aligning timelines with your travel plans.

flight_takeoff

Travel, Visa & Logistics Support

We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.

support_agent

Follow-Up & Continuity of Care

After your consultation or treatment, CancerFax facilitates communication between Dr. Baruch Brenner's team and your home oncologist for seamless post-treatment follow-up.

quiz

Frequently Asked Questions About Prof. Baruch Brenner

Prof. Baruch Brenner specialises in gastrointestinal malignancies, including colorectal cancer, colon cancer, rectal cancer, gastric cancer, oesophagogastric junction cancer, and biliary tract cancer. These are listed as his primary areas of clinical and research focus by Tel Aviv University's Cancer Biology Research Center.

Prof. Brenner is associated with the Davidoff Cancer Center at Rabin Medical Center in Israel, where he serves as Director. He also holds an academic position as Associate Professor of Oncology at the Sackler School of Medicine, Tel Aviv University.

CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Brenner, subject to hospital availability and case acceptance. Please submit your medical reports through CancerFax to begin the process.

A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging scans, treatment history, and relevant test results. The CancerFax team will organise and prepare the case documentation for submission. The final consultation format and availability depend on the doctor's institution and schedule.

Yes. The Gastrointestinal Oncology Unit at Davidoff Cancer Center, where Prof. Brenner is a key figure, conducts Phase I to Phase IV clinical trials in gastrointestinal malignancies. Eligible patients may be evaluated for clinical trial participation during a consultation, subject to specific eligibility criteria and trial availability at the time of review.

You can submit your medical documents — including pathology reports, imaging scans, lab results, and treatment summaries — through the CancerFax report upload portal. The CancerFax team will review your case, prepare a structured medical summary, and coordinate the next steps with the hospital or doctor's office, subject to availability and case acceptance.

sendGet Expert Oncology Guidance

Connect with Baruch Brenner Today

Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.

Free case review · No commitment · Response within 24 hours · Available in 12+ languages

Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.

upload_fileUpload ReportschatWhatsApp